Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 5Radiation Injuries 2Head and Neck Neoplasms 2Glioblastoma 2Esophageal Neoplasms 2Cardiotoxicity 2Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Smoking 1Rectal Neoplasms 1Ototoxicity 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphatic Metastasis 1Locally Advanced Cervical Cancer 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Heart Diseases 1Hearing Loss 1Cognitive Dysfunction 1Cholangiocarcinoma 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery 1

Interventions

Echocardiography 11Electrocardiography 5Trastuzumab 4Social Determinants of Health 2Doxorubicin 2Chemoradiotherapy 2Blood Specimen Collection 2Antineoplastic Agents 2Vascular Stiffness 1Standard of Care 1Resistance Training 1Pulse Wave Analysis 1Positron Emission Tomography Computed Tomography 1Magnetic Resonance Spectroscopy 1Immunomodulating Agents 1Hematologic Tests 1Gonadal Steroid Hormones 1Exercise Test 1EGFR tyrosine kinase inhibitor 324674 1Clinical Laboratory Techniques 1Cisplatin 1Cardiography, Impedance 1Anthracyclines 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Cardiotoxicity × Chemoradiotherapy × Clear all
NCT04305613 2025-10-02

CLARITY

Abramson Cancer Center at Penn Medicine

Active not recruiting
221 enrolled
Thoracic

Cardiovascular Diseases, Lung Neoplasms, Radiation Injuries, Cardiotoxicity

NCT05258448 2023-12-06

COLA

Odense University Hospital

Recruiting
100 enrolled
Thoracic

Heart Diseases, Lung Neoplasms, Radiation Injuries, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡